1. Home
  2. VSTS vs BCRX Comparison

VSTS vs BCRX Comparison

Compare VSTS & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vestis Corporation

VSTS

Vestis Corporation

N/A

Current Price

$14.37

Market Cap

2.0B

Sector

N/A

ML Signal

N/A

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

N/A

Current Price

$7.66

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VSTS
BCRX
Founded
1936
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
2023
1995

Fundamental Metrics

Financial Performance
Metric
VSTS
BCRX
Price
$14.37
$7.66
Analyst Decision
Hold
Buy
Analyst Count
8
11
Target Price
$13.00
★ $20.55
AVG Volume (30 Days)
1.2M
★ 5.1M
Earning Date
11-30-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 381.40
EPS
★ 0.05
N/A
Revenue
★ $2,734,839,000.00
$25,186,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.76
$3.71
P/E Ratio
$296.00
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$5.00
$6.23
52 Week High
$16.90
$11.22

Technical Indicators

Market Signals
Indicator
VSTS
BCRX
Relative Strength Index (RSI) 48.87 41.57
Support Level $13.03 $6.23
Resistance Level $15.05 $10.05
Average True Range (ATR) 0.58 0.39
MACD -0.09 -0.02
Stochastic Oscillator 39.39 19.68

Price Performance

Historical Comparison
VSTS
BCRX

About VSTS Vestis Corporation

Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: